These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12918940)

  • 21. Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide.
    Huang DF; Tsai ST; Wang SR
    Transfus Sci; 1994 Sep; 15(3):283-8. PubMed ID: 10155546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelitis and Lupus: Clinical Manifestations, Diagnosis and Treatment. Review.
    Chiganer EH; Hryb JP; Carnero Contentti E
    Reumatol Clin; 2017; 13(6):344-348. PubMed ID: 27567298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.
    Yu HH; Lee JH; Wang LC; Yang YH; Chiang BL
    Lupus; 2006; 15(10):651-7. PubMed ID: 17120591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus.
    Schroeder JO; Euler HH
    Adv Exp Med Biol; 1989; 260():203-13. PubMed ID: 2624244
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus.
    Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
    Cochrane Database Syst Rev; 2000; (3):CD002265. PubMed ID: 10908541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse cyclophosphamide for severe neuropsychiatric lupus.
    Boumpas DT; Yamada H; Patronas NJ; Scott D; Klippel JH; Balow JE
    Q J Med; 1991 Dec; 81(296):975-84. PubMed ID: 1808642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rituximab therapy for severe pediatric systemic lupus erythematosus].
    Su GX; Wu FQ; Wang F; Zhou ZX; Huang XL; Lu J
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):697-704. PubMed ID: 23158822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
    Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002265. PubMed ID: 16625558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
    Rizos T; Siegelin M; Hähnel S; Storch-Hagenlocher B; Hug A
    Lupus; 2009 Apr; 18(4):361-3. PubMed ID: 19276305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
    Fang H; Lan L; Qu Y; Zhang Q; Lv J
    J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
    Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
    Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rituximab as treatment for thrombocytopenic thrombotic purpura associated with systemic lupus erythematosus].
    López Carmona D; Pérez de Pedro I; de Ramón E; Camps García MT
    Med Clin (Barc); 2007 Dec; 129(20):797-8. PubMed ID: 18093482
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus.
    Ramos PC; Mendez MJ; Ames PR; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1996; 14(3):295-9. PubMed ID: 8809444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach.
    Sanna G; Bertolaccini ML; Khamashta MA
    Curr Pharm Des; 2008; 14(13):1261-9. PubMed ID: 18537650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit in long-term response and mortality of treatment with intravenous immunoglobulin prior to plasmapheresis in peripheral polyneuropathies.
    Parra-Salinas I; González-Rodríguez VP; Gracia Pina JA; Gimeno Lozano JJ; García-Erce JA
    Transfus Clin Biol; 2017 Feb; 24(1):9-14. PubMed ID: 27865608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system vasculitis in systemic lupus erythematosus: a case series report in a tertiary referral centre.
    Rodrigues M; Galego O; Costa C; Jesus D; Carvalho P; Santiago M; Malcata A; Inês L
    Lupus; 2017 Nov; 26(13):1440-1447. PubMed ID: 28420057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.
    Pryor BD; Bologna SG; Kahl LE
    Arthritis Rheum; 1996 Sep; 39(9):1475-82. PubMed ID: 8814058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
    Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.